Dr. Schott is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Nutcracker Therapeutics
5858 Horton Street, Suite 540
Emeryville, CA 94608Phone+1 916-956-1850
Summary
- I'm currently the Chief Medical Officer at Nutcracker Therapeutics focused on bringing novel mRNA therapies to the clinic.
Education & Training
- Massachusetts General HospitalFellowship, Cardiovascular Disease, 1990 - 1994
- The University of Michigan School of Public HealthMPH, Epidemiology, 1988
- University of MichiganResidency, Internal Medicine, 1981 - 1984
- University of Michigan Medical SchoolClass of 1981
- The University of MichiganBS, Biomedicine, 1980
Certifications & Licensure
- CA State Medical License 1994 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Clinical LipidologyDiplomate
Awards, Honors, & Recognition
- Teacher of the Year Deborah Heart and Lung Center, 2010
- Outstanding Role Model of the Year (Fellows Class of 2010) Deborah Heart and Lung Center, 2010
- Burgher Fellowship Award American Heart Association, 1991
- Join now to see all
Publications & Presentations
PubMed
- 16 citationsNeutrophil depletion fails to modify myocardial no reflow and functional recovery after coronary reperfusion.Robert E. Carlson, Robert J. Schott, Andrew J. Buda
Journal of the American College of Cardiology. 1989-12-01 - 1 citationsRadiation resistant PIDECα cell using photon intermediate direct energy conversion and a 210Po source.Charles L. Weaver, Robert J. Schott, Mark A. Prelas, Denis A. Wisniewski, Jason B. Rothenberger
Applied Radiation and Isotopes. 2018-02-01 - 4 citationsEfficacy and Safety of LY3127804, an Anti-Angiopoietin-2 Antibody, in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial in Patients Hospitalized with Pneum...Rosie S Jones, Patricia S Smith, Paul H Berg, Amparo de la Peña, Paul P Cook
Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine. 2022-01-01
Journal Articles
- Generation and Localization of Monoclonal Antibodies against Fibroblast Growth Factors in Ischaemic, Collateralized Porcine MyocardiumBernotat-Danielowski S, Sharma HS, Schott RJ, Schaper W, Cardiovasc Res, 1/1/1993
- Gene Injection into the Canine Myocardium as a Useful Model for Studying Gene Expression in the Heart of Large Mammalsvon Harsdorf R, Schott RJ, Shen Y-T, Vatner SF, Mahdavi V, Nadal-Ginard B, Circ Res, 1/1/1993
- Growth Factors and AngiogenesisSchott RJ, Morrow LA, Cardiovasc Res, 1/1/1993
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Rapid Glycometabolic Improvement in Type 2 Diabetic (T2D) Patients with an ADA Isocaloric Diet over a 22 Day Confinement in a Phase I Research UnitSchott RJ, Gomez K, Stern R, McCleary J, Krentz A, Morrow L, Hompesch M, National Lipid Association, 1/1/2012
- Anemia subsequent to Repeated Phlebotomy in Type 2 Diabetics (T2D) participating in a Phase I TrialSchott RJ, Angeles JE, Larrabee H, Humphreys C, Schott KM, Morrow LA, Hompesch M, American Society for Clinical Pharmacology and Therapeutics, 1/1/2012
- Effect of Discontinuing Oral Adnti-Diabetic Drugs (OAD) Prior to Enrollment in a Phase I TrialSchott RJ, Angeles JE, Larrabee H, Humphreys C, Schott KM, Morrow LA, Hompesch M, American Society for Clinical Pharmacology and Therapeutics, 1/1/2012
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: